Journals / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 5

The role of FAS gene variants in inflammatory bowel disease

Pages
356–361
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the FAS −1377G/A polymorphism, frequencies of the G allele and GG genotype were observed to be protective against IBD, whereas AA, GA genotypes, and A allele frequency increased in the patient group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: The analysis of genes thought to be important in inflammatory bowel disease (IBD) has shown that more than half of IBD-related genes are also associated with other autoimmune diseases.
📊
Key Findings & Data:The aim of this study was to detect a possible association between the polymorphisms of the (−670 A/G, −1377 G/A) fFas cell surface death receptor (FAS) gene promoter and susceptibility to IBD in the Turkish population.
💡
Conclusion & Impact:In the FAS −1377G/A polymorphism, frequencies of the G allele and GG genotype were observed to be protective against IBD, whereas AA, GA genotypes, and A allele frequency increased in the patient group.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: The analysis of genes thought to be important in inflammatory bowel disease (IBD) has shown that more than half of IBD-related genes are also associated with other autoimmune diseases. The aim of this study was to detect a possible association between the polymorphisms of the (−670 A/G, −1377 G/A) fFas cell surface death receptor (FAS) gene promoter and susceptibility to IBD in the Turkish population. Materials and Methods: In total, 125 patients with IBD, including 73 ulcerative colitis and 52 Crohn’s disease and also 101 healthy con-trols without any pathological signs of IBD were considered for the study. Real-time polymerase chain reaction technique was used to detect FAS polymorphisms in this study. Results: The analysis of FAS −670 A/G polymorphism indicated that the frequency of GG genotype was significantly increased in patients compared with controls (p<0.001). Additionally, AG genotype (p<0.001) and A allele (p<0.001) frequencies were higher in controls than in patients. The analysis of FAS −1377 G/A polymorphism revealed that the frequency of AA genotype was meaningfully increased in patients compared with controls (p<0.001). Additionally, GG genotype (p<0.001) and G allele (p<0.001) frequencies were increased in controls when compared with patients. Conclusion: FAS −670A/G GG genotype seemed to be a protective allele against IBD; however, AA genotype and A allele were associated with elevated risk of IBD. In the FAS −1377G/A polymorphism, frequencies of the G allele and GG genotype were observed to be protective against IBD, whereas AA, GA genotypes, and A allele frequency increased in the patient group.

🔖

Cite This Article

DEMİR, A., KAHRAMAN, R., CANDAN, G., ERGEN, H. A. (2020). The role of FAS gene variants in inflammatory bowel disease. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 5, 356–361. https://ajindex.com/articles/409198

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Abraham J, Cho JH. Inflammatory Bowel Disease. N Engl J Med 2009
  2. [Crossref] 2. Geboes K, Van Eyken P. Inflammatory bowel disease unclassified and in determinate colitis: the role of the pathologist. J Clin Pathol 2009
  3. [Crossref] 3. Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013
  4. [Crossref] 4. Ordás I, Mould DR, Feagan BG, Sandborn WJ. Anti-TNF monoclonal antibodies in inflammatory bowel disease: pharmacokinetics-based dosing paradigms. Clin Pharmacol Ther 2012
  5. [Crossref] 5. Bernstein CN. Treatment of IBD: where we are and where we are going. Am J Gastroenterol 2015
  6. [Crossref] 6. de Lange KM, Moutsianas L, Lee JC, et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. Nat Genet 2017
  7. [Crossref] 7. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 2015
  8. [Crossref] 8. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012
  9. [Crossref] 9. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 2008
  10. [Crossref] 10. Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 2013
  11. [Crossref] 11. Tavares M, de Lima C, Fernandes W, et al. Tumour necrosis factor-alpha (-308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patients. Int J Immunogenet 2016
  12. [Crossref] 12. Lichter P, Walczak H, Weitz S, Behrmann I, Krammer PH. The human APO-1 (APT) antigen maps to 10q23, a region that is syntenic with mouse chromosome 19. Genomics 1992
  13. [Crossref] 13. Wajant H. The Fas signaling pathway: more than a paradigm. Science 2002
  14. [Crossref] 14. Inazawa J, Itoh N, Abe T, Nagata S. Assignment of the human Fas antigen gene (Fas) to 10q24.1. Genomics 1992
  15. [Crossref] 15. Ma Y, Liu H, Tu-Rapp H, et al. Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol 200